Hydra Biosciences and Boehringer Ingelheim enter research collaboration to identify small-molecule TRP inhibitors for the treatment of renal diseases and disorders

Published 14, April 2015 at 132 × 172 in Hydra Biosciences and Boehringer Ingelheim enter research collaboration to identify small-molecule TRP inhibitors for the treatment of renal diseases and disorders

Dr. Michel Pairet, Senior Corporate Vice President of Research and Non-clinical Development at Boehringer Ingelheim

Dr. Michel Pairet, Senior Corporate Vice President of Research and Non-clinical Development at Boehringer Ingelheim

Bookmark the permalink.

Comments are closed.